NO144849C - Fremgangsmaate for fremstilling av 7-(d-alfa-amino-1,4-cyklo-heksadien-1-ylacetamido)-desacetoksycefalosporansyre-dihydrat - Google Patents

Fremgangsmaate for fremstilling av 7-(d-alfa-amino-1,4-cyklo-heksadien-1-ylacetamido)-desacetoksycefalosporansyre-dihydrat

Info

Publication number
NO144849C
NO144849C NO2277/73A NO227773A NO144849C NO 144849 C NO144849 C NO 144849C NO 2277/73 A NO2277/73 A NO 2277/73A NO 227773 A NO227773 A NO 227773A NO 144849 C NO144849 C NO 144849C
Authority
NO
Norway
Prior art keywords
desacetoxyce
ylacetamido
hexadien
alfa
cyclo
Prior art date
Application number
NO2277/73A
Other languages
English (en)
Norwegian (no)
Other versions
NO144849B (no
Inventor
Friedrich Duersch
Theodore Michael Siewarga
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of NO144849B publication Critical patent/NO144849B/no
Publication of NO144849C publication Critical patent/NO144849C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/227-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
NO2277/73A 1972-06-01 1973-05-30 Fremgangsmaate for fremstilling av 7-(d-alfa-amino-1,4-cyklo-heksadien-1-ylacetamido)-desacetoksycefalosporansyre-dihydrat NO144849C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00258767A US3819620A (en) 1972-06-01 1972-06-01 7-(d-alpha-amino-1,4-cyclohexadien-1-ylacet-amido)desacetoxycephalosporanic acid dihydrate

Publications (2)

Publication Number Publication Date
NO144849B NO144849B (no) 1981-08-17
NO144849C true NO144849C (no) 1981-11-25

Family

ID=22982041

Family Applications (1)

Application Number Title Priority Date Filing Date
NO2277/73A NO144849C (no) 1972-06-01 1973-05-30 Fremgangsmaate for fremstilling av 7-(d-alfa-amino-1,4-cyklo-heksadien-1-ylacetamido)-desacetoksycefalosporansyre-dihydrat

Country Status (30)

Country Link
US (1) US3819620A (en:Method)
JP (1) JPS5544754B2 (en:Method)
KR (1) KR820001606B1 (en:Method)
AR (1) AR196669A1 (en:Method)
AT (1) AT322740B (en:Method)
AU (1) AU475833B2 (en:Method)
BE (1) BE800373A (en:Method)
BR (1) BR7303959D0 (en:Method)
CA (1) CA1004220A (en:Method)
CH (1) CH582185A5 (en:Method)
CS (1) CS178428B2 (en:Method)
DD (1) DD106181A5 (en:Method)
DE (1) DE2326880C2 (en:Method)
EG (1) EG11139A (en:Method)
ES (1) ES415420A1 (en:Method)
FI (1) FI57952C (en:Method)
FR (1) FR2186234B1 (en:Method)
GB (1) GB1426266A (en:Method)
HU (1) HU167052B (en:Method)
IE (1) IE38750B1 (en:Method)
IL (1) IL42243A (en:Method)
IN (1) IN138787B (en:Method)
IT (1) IT1068202B (en:Method)
NL (1) NL176267C (en:Method)
NO (1) NO144849C (en:Method)
PL (1) PL87262B1 (en:Method)
RO (2) RO68286A (en:Method)
SE (1) SE409714B (en:Method)
SU (1) SU465793A3 (en:Method)
ZA (1) ZA732889B (en:Method)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5725557B2 (en:Method) * 1972-11-17 1982-05-29
CH619233A5 (en:Method) * 1975-07-31 1980-09-15 Ciba Geigy Ag
US4054738A (en) * 1975-12-22 1977-10-18 Eli Lilly And Company Sodium cefamandole crystalline forms
US4946838A (en) * 1981-07-13 1990-08-07 E. R. Squibb & Sons, Inc. Crystalline anhydrous aztreonam
NZ220764A (en) * 1986-07-02 1989-09-27 Shionogi & Co Crystalline form of 7beta((z)-2-(2-aminothiazol-4-yl)-4- carboxybut-2-enoylamino)-3-cephem-4-carboxylic acid and pharmaceutical compositions
US4977257A (en) * 1988-11-14 1990-12-11 Eli Lilly And Company DMF solvates of a β-lactam antibiotic
US5278157A (en) * 1989-07-10 1994-01-11 Gema, S.A. Stable cephradine hydrate
ES2023560A6 (es) * 1989-07-10 1992-01-16 Gema Sa Procedimiento para la produccion de hidrato de cefradina y solvato de cefradina y dimetilformamida.
IT1289955B1 (it) * 1997-02-21 1998-10-19 Solchem Italiana Spa Acyclovir sale sodico biidrato e sua preparazione
CN1326860C (zh) * 2002-08-06 2007-07-18 北京化工大学 头孢拉定晶体以及制备头孢拉定的方法
BRPI0412302A (pt) * 2003-07-03 2006-06-13 Dsm Ip Assets Bv processo para a preparação de cefradina
CN104688713A (zh) * 2015-03-20 2015-06-10 江苏亚邦强生药业有限公司 一种头孢拉定胶囊剂及其制备方法
CN112206217A (zh) * 2020-10-21 2021-01-12 迪沙药业集团有限公司 一种头孢拉定药物组合物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485819A (en) * 1968-07-02 1969-12-23 Squibb & Sons Inc Alpha-amino-cyclohexadienylalkylene-penicillins and cephalosporins

Also Published As

Publication number Publication date
FI57952B (fi) 1980-07-31
BE800373A (fr) 1973-12-03
NL176267C (nl) 1985-03-18
DE2326880A1 (de) 1973-12-20
KR820001606B1 (ko) 1982-09-08
IE38750L (en) 1973-12-01
ES415420A1 (es) 1976-02-16
FR2186234B1 (en:Method) 1976-10-22
FI57952C (fi) 1981-09-07
IE38750B1 (en) 1978-05-24
IL42243A (en) 1975-10-15
NL7307321A (en:Method) 1973-12-04
IN138787B (en:Method) 1976-03-27
NO144849B (no) 1981-08-17
SU465793A3 (ru) 1975-03-30
JPS5544754B2 (en:Method) 1980-11-13
CH582185A5 (en:Method) 1976-11-30
DD106181A5 (en:Method) 1974-06-05
EG11139A (en) 1978-03-29
AR196669A1 (es) 1974-02-12
SE409714B (sv) 1979-09-03
IL42243A0 (en) 1973-07-30
AU5507473A (en) 1974-11-07
AU475833B2 (en) 1976-09-02
CA1004220A (en) 1977-01-25
BR7303959D0 (pt) 1974-08-29
CS178428B2 (en:Method) 1977-09-15
GB1426266A (en) 1976-02-25
US3819620A (en) 1974-06-25
HU167052B (en:Method) 1975-07-28
RO68286A (ro) 1980-12-30
IT1068202B (it) 1985-03-21
FR2186234A1 (en:Method) 1974-01-11
AT322740B (de) 1975-06-10
ZA732889B (en) 1974-04-24
RO63443A (fr) 1978-07-15
JPS4941520A (en:Method) 1974-04-18
DE2326880C2 (de) 1982-04-15
PL87262B1 (en:Method) 1976-06-30

Similar Documents

Publication Publication Date Title
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE7700442L (sv) Forfarande for framstellning av 6-aminopenicillansyra
SE385698B (sv) Forfarande for framstellning av kinolinettiksyraderivat
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
NO144849C (no) Fremgangsmaate for fremstilling av 7-(d-alfa-amino-1,4-cyklo-heksadien-1-ylacetamido)-desacetoksycefalosporansyre-dihydrat
SE414164B (sv) Forfarande for framstellning av fosforsyra
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE416473B (sv) Forfarande for framstellning av 7-(alfa-hydroxi-alfa-fenyl) acetamido-3-(1-metyl-1h-tetrazol-5-yltiometyl)-3-cefem-4-karbonsyra
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
SE402009B (sv) Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE393808B (sv) Forfarande for framstellning av isomaltit
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
SE421424B (sv) Analogiforfarande for framstellning av lysergsyraamider
NO140736C (no) Fremgangsmaate til fremstilling av poly-alfa-oksyakrylsyre
NO142307C (no) Fremgangsmaate ved fremstilling av pregnansyrederivater
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
NO139890C (no) Fremgangsmaate ved fremstilling av n5 -methyltetrahydrohomofolinsyre
SE389862B (sv) Forfarande for framstellning av alfa-6-deoxitetracykliner
SE396377B (sv) Forfarande for framstellning av difenylmetoxietylaminer